ATE400271T1 - Aryl-pyridinderivate als 11-beta-hsd1-hemmer - Google Patents
Aryl-pyridinderivate als 11-beta-hsd1-hemmerInfo
- Publication number
- ATE400271T1 ATE400271T1 AT05776709T AT05776709T ATE400271T1 AT E400271 T1 ATE400271 T1 AT E400271T1 AT 05776709 T AT05776709 T AT 05776709T AT 05776709 T AT05776709 T AT 05776709T AT E400271 T1 ATE400271 T1 AT E400271T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- aryl
- pyridine derivatives
- hsd1 inhibitors
- hsd1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103639 | 2004-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE400271T1 true ATE400271T1 (de) | 2008-07-15 |
Family
ID=35427898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05776709T ATE400271T1 (de) | 2004-07-28 | 2005-07-20 | Aryl-pyridinderivate als 11-beta-hsd1-hemmer |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7528159B2 (de) |
| EP (1) | EP1789041B1 (de) |
| JP (1) | JP4690402B2 (de) |
| KR (1) | KR100926842B1 (de) |
| CN (1) | CN100589803C (de) |
| AR (1) | AR049739A1 (de) |
| AT (1) | ATE400271T1 (de) |
| AU (1) | AU2005266531B2 (de) |
| BR (1) | BRPI0513864A (de) |
| CA (1) | CA2574875C (de) |
| DE (1) | DE602005008079D1 (de) |
| DK (1) | DK1789041T3 (de) |
| ES (1) | ES2309789T3 (de) |
| HR (1) | HRP20080477T3 (de) |
| IL (1) | IL180481A (de) |
| MX (1) | MX2007000789A (de) |
| MY (1) | MY138941A (de) |
| NO (1) | NO20070458L (de) |
| NZ (1) | NZ552398A (de) |
| PL (1) | PL1789041T3 (de) |
| PT (1) | PT1789041E (de) |
| RU (1) | RU2374239C2 (de) |
| SI (1) | SI1789041T1 (de) |
| TW (1) | TW200608972A (de) |
| WO (1) | WO2006010546A2 (de) |
| ZA (1) | ZA200700181B (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100589803C (zh) * | 2004-07-28 | 2010-02-17 | 霍夫曼-拉罗奇有限公司 | 芳基-吡啶衍生物 |
| WO2006106423A2 (en) * | 2005-04-07 | 2006-10-12 | Pfizer Inc. | Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| RU2008132333A (ru) * | 2006-02-07 | 2010-03-20 | Вайет (Us) | Ингибиторы 11-бета hsd1 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| US20100022572A1 (en) | 2008-07-18 | 2010-01-28 | Kowa Company, Ltd. | Novel spiro compound and medicine comprising the same |
| EP2322505A4 (de) | 2008-08-29 | 2011-10-19 | Kowa Co | 1-adamantylazetidin-2-on-derivat, herstellung davon und pharmazeutisches präparat damit |
| JP5477973B2 (ja) | 2008-10-29 | 2014-04-23 | 興和株式会社 | １，２−ジアゼチジン−３−オン誘導体及びこれを含有する医薬 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| MY184008A (en) | 2009-05-15 | 2021-03-17 | Novartis Ag | Aryl pyridine as aldosterone synthase inhibitors |
| ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
| WO2011068927A2 (en) * | 2009-12-04 | 2011-06-09 | Abbott Laboratories | 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11B-HSD1) INHIBITORS AND USES THEREOF |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2686302B1 (de) * | 2011-03-16 | 2016-08-10 | Mitsubishi Tanabe Pharma Corporation | Sulfonamidverbindungen mit trpm8-antagonistischer aktivität |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (de) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren |
| US9458147B2 (en) * | 2012-02-22 | 2016-10-04 | Sanford-Burnham Medical Research Institute | Sulfonamide compounds and uses as TNAP inhibitors |
| RU2015124564A (ru) * | 2012-12-10 | 2017-01-12 | Ф. Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ БЕНЗОЛСУЛЬФОНАМИДА В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРОВ RORc |
| CN105175323B (zh) * | 2015-09-16 | 2017-12-22 | 浙江海翔药业股份有限公司 | 一种制备2‑（4‑乙酰胺基苯磺酰基）胺基吡啶的方法 |
| US20210221784A1 (en) * | 2018-02-05 | 2021-07-22 | Université De Strasbourg | Compounds and compositions for the treatment of pain |
| CN112074505B (zh) | 2018-03-08 | 2024-04-05 | 因赛特公司 | 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物 |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| KR102418518B1 (ko) * | 2020-08-05 | 2022-07-07 | 성균관대학교산학협력단 | 설퍼 일라이드를 이용한 n-헤테로고리의 선택적 알킬화 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2159938A1 (en) * | 1994-10-07 | 1996-04-08 | Hiroaki Yanagisawa | Oxime derivatives, their preparation and their therapeutic use |
| CN1633428A (zh) * | 2001-11-22 | 2005-06-29 | 比奥维特罗姆股份公司 | 11－β－羟基类固醇脱氢酶1型抑制剂 |
| MXPA04004779A (es) * | 2001-11-22 | 2004-07-30 | Biovitrum Ab | Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1. |
| BR0312957A (pt) * | 2002-07-27 | 2005-06-14 | Astrazeneca Ab | Composto ou um sal farmaceuticamente aceitável deste, uso do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, em necessidade de tal tratamento |
| CN100589803C (zh) * | 2004-07-28 | 2010-02-17 | 霍夫曼-拉罗奇有限公司 | 芳基-吡啶衍生物 |
-
2005
- 2005-07-20 CN CN200580025005A patent/CN100589803C/zh not_active Expired - Fee Related
- 2005-07-20 PL PL05776709T patent/PL1789041T3/pl unknown
- 2005-07-20 BR BRPI0513864-7A patent/BRPI0513864A/pt not_active IP Right Cessation
- 2005-07-20 AU AU2005266531A patent/AU2005266531B2/en not_active Ceased
- 2005-07-20 KR KR1020077002036A patent/KR100926842B1/ko not_active Expired - Fee Related
- 2005-07-20 PT PT05776709T patent/PT1789041E/pt unknown
- 2005-07-20 MX MX2007000789A patent/MX2007000789A/es active IP Right Grant
- 2005-07-20 RU RU2007107189/04A patent/RU2374239C2/ru not_active IP Right Cessation
- 2005-07-20 EP EP05776709A patent/EP1789041B1/de not_active Expired - Lifetime
- 2005-07-20 JP JP2007522984A patent/JP4690402B2/ja not_active Expired - Fee Related
- 2005-07-20 DK DK05776709T patent/DK1789041T3/da active
- 2005-07-20 DE DE602005008079T patent/DE602005008079D1/de not_active Expired - Lifetime
- 2005-07-20 CA CA2574875A patent/CA2574875C/en not_active Expired - Fee Related
- 2005-07-20 NZ NZ552398A patent/NZ552398A/en not_active IP Right Cessation
- 2005-07-20 SI SI200530343T patent/SI1789041T1/sl unknown
- 2005-07-20 ES ES05776709T patent/ES2309789T3/es not_active Expired - Lifetime
- 2005-07-20 AT AT05776709T patent/ATE400271T1/de active
- 2005-07-20 HR HR20080477T patent/HRP20080477T3/xx unknown
- 2005-07-20 WO PCT/EP2005/007894 patent/WO2006010546A2/en not_active Ceased
- 2005-07-25 TW TW094125138A patent/TW200608972A/zh unknown
- 2005-07-26 US US11/189,598 patent/US7528159B2/en not_active Expired - Fee Related
- 2005-07-26 AR ARP050103098A patent/AR049739A1/es unknown
- 2005-07-26 MY MYPI20053431A patent/MY138941A/en unknown
-
2007
- 2007-01-01 IL IL180481A patent/IL180481A/en not_active IP Right Cessation
- 2007-01-05 ZA ZA200700181A patent/ZA200700181B/xx unknown
- 2007-01-24 NO NO20070458A patent/NO20070458L/no not_active Application Discontinuation
-
2009
- 2009-02-17 US US12/372,244 patent/US8211913B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022001I1 (el) | Παραγωγα του uk-2a | |
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
| ATE452631T1 (de) | N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer | |
| ATE540936T1 (de) | Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer | |
| ATE446090T1 (de) | Thiadiazolidinone als gsk3-inhibitoren | |
| ATE452635T1 (de) | Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| ATE501138T1 (de) | Thiophenderivate als chk-1-inhibitoren | |
| ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| PT1586571E (pt) | Inibidores da dipeptidil-peptidase | |
| ATE478064T1 (de) | Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate | |
| DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
| ATE521607T1 (de) | Piperidinderivate als renin-inhibitoren | |
| ATE531705T1 (de) | Substituierte 2-chinolyloxazole geeignet als pde4 inhibitoren | |
| ATE540935T1 (de) | Chinazolinderivate | |
| DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
| ATE467623T1 (de) | Diazepan-acetamidderivate als selektive 11-hsd1- hemmer | |
| ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
| DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
| ATE462692T1 (de) | 3-amino-1-arylpropyl-indole als monoamin- wiederaufnahmehemmer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1789041 Country of ref document: EP |